{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:09:48Z","timestamp":1788318588708,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000181","name":"Air Force Office of Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007333","name":"Alzheimer's Disease Neuroimaging Initiative","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AstraZeneca AB"},{"name":"Bayer Schering Pharma AG"},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eisai Global Clinical Development"},{"DOI":"10.13039\/501100003037","name":"Elan Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001127","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005061","name":"Innogenetics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005061","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medpace, Inc"},{"DOI":"10.13039\/100004334","name":"Merck and Co, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffman-La Roche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007110","name":"Schering-Plough","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007110","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Synarc, Inc"},{"DOI":"10.13039\/100004342","name":"Wyeth","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004342","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009804","name":"Northern California Institute for Research and Education","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009804","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG010129"],"award-info":[{"award-number":["P30 AG010129"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01 AG030514"],"award-info":[{"award-number":["K01 AG030514"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001068","name":"Dana Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.neurobiolaging.2014.01.154","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T19:59:06Z","timestamp":1409428746000},"page":"S203-S210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"S1","title":["Higher homocysteine associated with thinner cortical gray matter in\u00a0803 participants from the Alzheimer's Disease Neuroimaging Initiative"],"prefix":"10.1016","volume":"36","author":[{"given":"Sarah K.","family":"Madsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantanu H.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur W.","family":"Toga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib1","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.neurobiolaging.2012.01.014","article-title":"Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults","volume":"33","author":"Alexander","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000103914","article-title":"Structural correlates of apathy in Alzheimer's disease","volume":"24","author":"Apostolova","year":"2007","journal-title":"Dement Geriatr. Cogn."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib3","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archneur.64.10.1489","article-title":"Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease","volume":"64","author":"Apostolova","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.nurt.2007.05.009","article-title":"Brain mapping as a tool to study neurodegeneration","volume":"4","author":"Apostolova","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib5","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ana.22333","article-title":"Amyloid-beta associated cortical thinning in clinically normal elderly","volume":"69","author":"Becker","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate - a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J.\u00a0Roy Stat. Soc. B Met."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archinte.159.10.1077","article-title":"Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women","volume":"159","author":"Bostom","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2796.1997.00239.x","article-title":"Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: the Rotterdam Study","volume":"242","author":"Bots","year":"1997","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0197-4580(99)00110-4","article-title":"Vascular risk factors for Alzheimer's disease: an epidemiologic perspective","volume":"21","author":"Breteler","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib10","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J.\u00a0Neurosci."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2014.01.154_bib11","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/HYPERTENSIONAHA.112.193409","article-title":"Association between ambulatory 24-hour blood pressure levels and brain volume reduction a cross-sectional elderly population-based study","volume":"60","author":"Celle","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcn\/82.4.806","article-title":"Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials","volume":"82","author":"Clarke","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.55.11.1449","article-title":"Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease","volume":"55","author":"Clarke","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/nimg.1998.0395","article-title":"Cortical surface-based analysis - I. Segmentation and surface reconstruction","volume":"9","author":"Dale","year":"1999","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/gps.2758","article-title":"Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial","volume":"27","author":"de Jager","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"Pt 1","key":"10.1016\/j.neurobiolaging.2014.01.154_bib17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awg006","article-title":"Homocysteine and brain atrophy on MRI of non-demented elderly","volume":"126","author":"den Heijer","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cercor\/bhn113","article-title":"The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals","volume":"19","author":"Dickerson","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.neurobiolaging.2007.07.022","article-title":"Differential effects of aging and Alzheimer's disease on medial temporal lobe cortical thickness and surface area","volume":"30","author":"Dickerson","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib20","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1212\/WNL.0b013e3181f88359","article-title":"Physical activity predicts gray matter volume in late adulthood the Cardiovascular Health Study","volume":"75","author":"Erickson","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brainres.2008.01.030","article-title":"Greater intake of vitamins B6 and B12 spares gray matter in healthy elderly: a voxel-based morphometry study","volume":"1199","author":"Erickson","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1017\/S1041610210000499","article-title":"Homocysteine is associated with hippocampal and white matter atrophy in older subjects with mild hypertension","volume":"22","author":"Firbank","year":"2010","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib24","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1073\/pnas.200033797","article-title":"Measuring the thickness of the human cerebral cortex from magnetic resonance images","volume":"97","author":"Fischl","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib25","doi-asserted-by":"crossref","first-page":"e33345","DOI":"10.1371\/journal.pone.0033345","article-title":"Homocysteine, grey matter and cognitive function in adults with cardiovascular disease","volume":"7","author":"Ford","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib26","first-page":"916","article-title":"In\u00a0vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease","volume":"256","author":"Frisoni","year":"2009","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib27","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1006\/nimg.2001.1037","article-title":"Thresholding of statistical maps in functional neuroimaging using the false discovery rate","volume":"15","author":"Genovese","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib28","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1212\/01.WNL.0000141850.47773.5F","article-title":"A\u00a024-year follow-up of body mass index and cerebral atrophy","volume":"63","author":"Gustafson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib29","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.1073\/pnas.0910878107","article-title":"A\u00a0commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly","volume":"107","author":"Ho","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.neuroimage.2012.10.086","article-title":"Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials","volume":"66","author":"Hua","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J.\u00a0Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jalz.2011.11.008","article-title":"Homocysteine, progression of ventricular enlargement, and cognitive decline. The second manifestations of ARTerial disease-magnetic resonance study","volume":"9","author":"Jochemsen","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1532-5415.2010.03219.x","article-title":"Interaction between body mass index and central adiposity and risk of incident cognitive impairment and dementia: results from the women's health initiative memory study","volume":"59","author":"Kerwin","year":"2011","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib34","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1532-5415.2010.02969.x","article-title":"The cross-sectional relationship between body mass index, waist-hip ratio, and cognitive performance in postmenopausal women enrolled in the women's health initiative","volume":"58","author":"Kerwin","year":"2010","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.nicl.2013.04.012","article-title":"Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: results from the psychological, social and biological determinants of ill health (pSoBid) study","volume":"2","author":"Krishnadas","year":"2013","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib36","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","article-title":"Homocysteine elicits a DNA damage response in neurons that promotes\u00a0apoptosis and hypersensitivity to excitotoxicity","volume":"20","author":"Kruman","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000017092","article-title":"Identification of cognitive impairment in the elderly: homocysteine is an early marker","volume":"10","author":"Lehmann","year":"1999","journal-title":"Dement. Geriatr. Cogn."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/11505730_41","article-title":"Inverse consistent mapping in 3D deformable image registration: its construction and statistical properties","volume":"19","author":"Leow","year":"2005","journal-title":"Inf Process Med Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib39","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.neuroimage.2010.10.050","article-title":"Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults","volume":"54","author":"Leritz","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib40","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","article-title":"Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor","volume":"94","author":"Lipton","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pscychresns.2013.06.004","article-title":"Frontal cortical thinning and subcortical volume reductions in early adulthood obesity","volume":"214","author":"Marques-Iturria","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib42","first-page":"CD006612","article-title":"Homocysteine-lowering interventions for preventing cardiovascular events","volume":"1","author":"Marti-Carvajal","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10548-011-0198-6","article-title":"Age-related changes in the thickness of cortical zones in humans","volume":"24","author":"McGinnis","year":"2011","journal-title":"Brain Topogr."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib44","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/ajcn\/73.5.927","article-title":"Hyperhomocysteinemia associated with poor recall in the third national health and nutrition examination survey","volume":"73","author":"Morris","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jalz.2005.06.003","article-title":"Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI)","volume":"1","author":"Mueller","year":"2005","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib46","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s11886-012-0304-8","article-title":"The dementia of cardiac disease","volume":"14","author":"Muqtadar","year":"2012","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/gps.2303","article-title":"Homocysteine as a predictor of cognitive decline in Alzheimer's disease","volume":"25","author":"Oulhaj","year":"2010","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib48","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/hbm.22120","article-title":"Sample size estimates for well-powered cross-sectional cortical thickness studies","volume":"34","author":"Pardoe","year":"2013","journal-title":"Hum. Brain Mapp"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib49","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(95)92407-8","article-title":"Prospective-study of serum total homocysteine concentration and risk of stroke in middle-aged British men","volume":"346","author":"Perry","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib50","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.neuroimage.2009.01.009","article-title":"Mapping the effect of APOE epsilon 4 on gray matter loss in Alzheimer's disease in\u00a0vivo","volume":"45","author":"Pievani","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib51","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3233\/JAD-2010-101191","article-title":"Cortical changes in incipient Alzheimer's disease","volume":"22","author":"Prestia","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/WNR.0b013e328346bf85","article-title":"Homocysteine effects on brain volumes mapped in 732 elderly individuals","volume":"22","author":"Rajagopalan","year":"2011","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib54","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.neurobiolaging.2012.10.022","article-title":"Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly","volume":"34","author":"Rajagopalan","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WNR.0b013e32835c5254","article-title":"Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly","volume":"24","author":"Rajagopalan","year":"2013","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hbm.20870","article-title":"Brain structure and obesity","volume":"31","author":"Raji","year":"2010","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neuroimage.2011.11.075","article-title":"Brain imaging in the study of Alzheimer's disease","volume":"61","author":"Reiman","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/ajcn\/63.3.306","article-title":"Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the normative aging study","volume":"63","author":"Riggs","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib59","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archneur.56.3.338","article-title":"Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease","volume":"56","author":"Salat","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuroimage.2011.07.033","article-title":"Inter-individual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults","volume":"59","author":"Salat","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib61","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199502023320502","article-title":"Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis","volume":"332","author":"Selhub","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-2010-1223","article-title":"Grey and white matter changes at different stages of Alzheimer's disease","volume":"19","author":"Serra","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib63","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer's disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000109755","article-title":"PENN biomarker core of the Alzheimer's disease Neuroimaging Initiative","volume":"16","author":"Shaw","year":"2008","journal-title":"Neurosignals"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib65","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1177\/15648265080292S119","article-title":"The worldwide challenge of the dementias: a role for B vitamins and homocysteine?","volume":"29","author":"Smith","year":"2008","journal-title":"Food Nutr. Bull."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib66","doi-asserted-by":"crossref","first-page":"e12244","DOI":"10.1371\/journal.pone.0012244","article-title":"Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial","volume":"5","author":"Smith","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12017-009-8109-7","article-title":"Functional alterations in memory networks in early Alzheimer's disease","volume":"12","author":"Sperling","year":"2010","journal-title":"Neuromol Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib68","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.51.4.986","article-title":"Association of midlife blood pressure to late-life cognitive decline and brain morphology","volume":"51","author":"Swan","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib69","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1523\/JNEUROSCI.23-03-00994.2003","article-title":"Dynamics of gray matter loss in Alzheimer's disease","volume":"23","author":"Thompson","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib70","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.neuroimage.2004.07.071","article-title":"Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia","volume":"23","author":"Thompson","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib71","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.biopsych.2013.01.004","article-title":"Connectomics sheds new light on Alzheimer's disease","volume":"73","author":"Toga","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib72","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jalz.2010.08.234","article-title":"Serum homocysteine and dementia: meta-analysis of eight cohort studies including 8669 participants","volume":"7","author":"Wald","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib73","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)01452-0","article-title":"Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people","volume":"341","author":"Whalley","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib74","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.neurobiolaging.2010.06.003","article-title":"Homocysteine, neural atrophy, and the effect of caloric restriction in rhesus monkeys","volume":"33","author":"Willette","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib75","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/ageing\/31.6.440","article-title":"Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people","volume":"31","author":"Williams","year":"2002","journal-title":"Age Ageing"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib76","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neurobiolaging.2012.10.011","article-title":"APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease","volume":"34","author":"Wolf","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib77","doi-asserted-by":"crossref","first-page":"10256","DOI":"10.1073\/pnas.1001412107","article-title":"Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease","volume":"107","author":"Wolk","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib78","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/hbm.21153","article-title":"Altered default mode network connectivity in Alzheimer's disease-a resting functional MRI and Bayesian network study","volume":"32","author":"Wu","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neurobiolaging.2014.01.154_bib79","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2012.06.004","article-title":"Standardization of analysis sets for reporting results from ADNI MRI data","volume":"9","author":"Wyman","year":"2013","journal-title":"Alzheimers Dement"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014005624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014005624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T03:40:30Z","timestamp":1717299630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458014005624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":77,"alternative-id":["S0197458014005624"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.01.154","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher homocysteine associated with thinner cortical gray matter in\u00a0803 participants from the Alzheimer's Disease Neuroimaging Initiative","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.01.154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}